Diabetes drug metformin may reduce risk of long Covid: Study

A new study suggests that taking the diabetes drug metformin after testing positive for Covid-19 may reduce the risk of developing long Covid by 40%. The US study published in the Lancet found that metformin prevented over 40% of cases of long Covid in the trial. However, further studies are needed to determine the effect of the medicine on those who already have long Covid.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wkMlEW0
via IFTTT